CBLL
CeriBell, IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$787.75M
P/E Ratio
—
EPS
$-1.46
Beta
—
52W High
$24.33
52W Low
$10.85
50-Day MA
$19.19
200-Day MA
$16.60
Dividend Yield
—
Profit Margin
-60.00%
Forward P/E
—
PEG Ratio
—
About CeriBell, Inc
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company is headquartered in Sunnyvale, California.
Fundamentals
| Revenue (TTM) | $89.06M |
| Gross Profit (TTM) | $78.27M |
| EBITDA | $-57.06M |
| Operating Margin | -58.90% |
| Return on Equity | -30.80% |
| Return on Assets | -17.30% |
| Revenue/Share (TTM) | $2.44 |
| Book Value | $4.14 |
| Price-to-Book | 5.07 |
| Price-to-Sales (TTM) | 8.84 |
| EV/Revenue | 7.31 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 33.70% |
| Shares Outstanding | $37.87M |
| Float | $24.37M |
| % Insiders | 11.79% |
| % Institutions | 84.75% |
Historical Volatility
HV 10-Day
44.39%
HV 20-Day
46.59%
HV 30-Day
43.47%
HV 60-Day
40.10%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($27.57 target)
1
Strong Buy7
BuyData last updated: 4/29/2026